Arcadia Biosciences, Inc. (GETTEX:17D) Financings
Financings
| Raise | Date |
|---|---|
| Private placement of common stock (or pre-funded warrants) with Series A-1 and A-2 preferred investment options Closed: US$4M raised · US$1.03 a share · Warrants at US$0.91 · H.C. Wainwright & Co. Dealers: H.C. Wainwright & Co. (lead) Use of proceeds: Working capital and general corporate purposes | Jun 13, 2026 |
| Warrant exercise of preferred investment options exercised for common stock Announced: about US$2.1M · US$2.575 a share · Warrants at US$2.325 for 30 months · H.C. Wainwright & Co. Dealers: H.C. Wainwright & Co. (lead) Use of proceeds: Working capital and general corporate purposes | Jan 12, 2026 |